Paper28322702
Significant Decrease in Pertactin-Deficient Bordetella pertussis Isolates, Japan.
Hiramatsu Y and 5 others. Emerg Infect Dis, 2017. Cited by 27 papers, by iCite.
Cite this record
ConductScience Library. Significant Decrease in Pertactin-Deficient Bordetella pertussis Isolates, Japan. Papers, record 28322702. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28322702
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bacterial Outer Membrane Proteins | Major topic |
| Bordetella pertussis | Major topic |
| Gene Expression Regulation, Bacterial | Major topic |
| Virulence Factors, Bordetella | Major topic |
| Evolution, Molecular | |
| Genotype | |
| Japan | |
| Mutation |
Source PubMed
References15
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19751581 | Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. | Emerg Infect Dis | 2009 | https://conductscience.org/library/papers/19751581 | PubMed |
| 2 | 25312274 | Pertactin deficient Bordetella pertussis present a better fitness in mice immunized with an acellular pertussis vaccine. | Vaccine | 2014 | https://conductscience.org/library/papers/25312274 | PubMed |
| 3 | 22348138 | Prevalence and genetic characterization of pertactin-deficient Bordetella pertussis in Japan. | PLoS One | 2012 | https://conductscience.org/library/papers/22348138 | PubMed |
| 4 | 1988935 | Pertactin, an Arg-Gly-Asp-containing Bordetella pertussis surface protein that promotes adherence of mammalian cells. | Proc Natl Acad Sci U S A | 1991 | https://conductscience.org/library/papers/1988935 | PubMed |
| 5 | 24256623 | Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States. | Clin Vaccine Immunol | 2014 | https://conductscience.org/library/papers/24256623 | PubMed |
| 6 | 25166348 | Investigations into the emergence of pertactin-deficient Bordetella pertussis isolates in six European countries, 1996 to 2012. | Euro Surveill | 2014 | https://conductscience.org/library/papers/25166348 | PubMed |
| 7 | 24124606 | Genetic analysis of Bordetella pertussis isolates from the 2008-2010 pertussis epidemic in Japan. | PLoS One | 2013 | https://conductscience.org/library/papers/24124606 | PubMed |
| 8 | 24655754 | Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia. | Emerg Infect Dis | 2014 | https://conductscience.org/library/papers/24655754 | PubMed |
| 9 | 19666155 | First report and detailed characterization of B. pertussis isolates not expressing Pertussis Toxin or Pertactin. | Vaccine | 2009 | https://conductscience.org/library/papers/19666155 | PubMed |
| 10 | 25301209 | Pertactin-negative Bordetella pertussis strains: evidence for a possible selective advantage. | Clin Infect Dis | 2015 | https://conductscience.org/library/papers/25301209 | PubMed |
| 11 | 23776625 | Genome-wide gene expression analysis of Bordetella pertussis isolates associated with a resurgence in pertussis: elucidation of factors involved in the increased fitness of epidemic strains. | PLoS One | 2013 | https://conductscience.org/library/papers/23776625 | PubMed |
| 12 | 20883738 | Safe and effective booster immunization using DTaP in teenagers. | Vaccine | 2010 | https://conductscience.org/library/papers/20883738 | PubMed |
| 13 | 22841154 | Population diversity among Bordetella pertussis isolates, United States, 1935-2009. | Emerg Infect Dis | 2012 | https://conductscience.org/library/papers/22841154 | PubMed |
| 14 | 26432908 | Pertactin negative Bordetella pertussis demonstrates higher fitness under vaccine selection pressure in a mixed infection model. | Vaccine | 2015 | https://conductscience.org/library/papers/26432908 | PubMed |
| 15 | 25527446 | Analysis of Bordetella pertussis clinical isolates circulating in European countries during the period 1998-2012. | Eur J Clin Microbiol Infect Dis | 2015 | https://conductscience.org/library/papers/25527446 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42368399 | Laboratory diagnosis of pertussis: A survey on provincial public health laboratory methods. | Can Commun Dis Rep | 2026 | https://conductscience.org/library/papers/42368399 | PubMed |
| 41438608 | Comparing frequentist and Bayesian methods to identify drivers of pathogen strain invasion: A temporal case study of pertussis in the United States. | Infect Dis Model | 2026 | https://conductscience.org/library/papers/41438608 | PubMed |
| 40709171 | Pertussis resurgence: epidemiological trends, pathogenic mechanisms, and preventive strategies. | Front Immunol | 2025 | https://conductscience.org/library/papers/40709171 | PubMed |
| 40366145 | Vaccine antigen-based genotyping of Bordetella pertussis by direct Sanger sequencing of clinical samples in Peru from 2018 to 2019. | Microbiol Spectr | 2025 | https://conductscience.org/library/papers/40366145 | PubMed |
| 39686838 | Pertactin deficiency of Bordetella pertussis: Insights into epidemiology, and perspectives on surveillance and public health impact. | Hum Vaccin Immunother | 2024 | https://conductscience.org/library/papers/39686838 | PubMed |
| 39447192 | Prevalence of Pertactin-Deficient Bordetella pertussis Isolates, Slovenia. | Emerg Infect Dis | 2024 | https://conductscience.org/library/papers/39447192 | PubMed |
| 36270447 | Genotyping and macrolide-resistant mutation of Bordetella pertussis in East and South-East Asia. | J Glob Antimicrob Resist | 2022 | https://conductscience.org/library/papers/36270447 | PubMed |
| 36047634 | Bordetella pertussis and outer membrane vesicles. | Pathog Glob Health | 2023 | https://conductscience.org/library/papers/36047634 | PubMed |
| 36032328 | Can vaccines control bacterial virulence and pathogenicity? Bordetella pertussis: the advantage of fitness over virulence. | Evol Med Public Health | 2022 | https://conductscience.org/library/papers/36032328 | PubMed |
| 35543837 | Evolution of Bordetella pertussis in the acellular vaccine era in Norway, 1996 to 2019. | Eur J Clin Microbiol Infect Dis | 2022 | https://conductscience.org/library/papers/35543837 | PubMed |
| 35447067 | Pertactin-Deficient Bordetella pertussis with Unusual Mechanism of Pertactin Disruption, Spain, 1986-2018. | Emerg Infect Dis | 2022 | https://conductscience.org/library/papers/35447067 | PubMed |
| 34533118 | Evolution of Bordetella pertussis over a 23-year period in France, 1996 to 2018. | Euro Surveill | 2021 | https://conductscience.org/library/papers/34533118 | PubMed |
| 34132167 | Naturally circulating pertactin-deficient Bordetella pertussis strains induce distinct gene expression and inflammatory signatures in human dendritic cells. | Emerg Microbes Infect | 2021 | https://conductscience.org/library/papers/34132167 | PubMed |
| 34014152 | Pertactin-Deficient Bordetella pertussis, Vaccine-Driven Evolution, and Reemergence of Pertussis. | Emerg Infect Dis | 2021 | https://conductscience.org/library/papers/34014152 | PubMed |
| 32983069 | Acellular Pertussis Vaccines Induce Anti-pertactin Bactericidal Antibodies Which Drives the Emergence of Pertactin-Negative Strains. | Front Microbiol | 2020 | https://conductscience.org/library/papers/32983069 | PubMed |
| 31333640 | Pertussis Prevention: Reasons for Resurgence, and Differences in the Current Acellular Pertussis Vaccines. | Front Immunol | 2019 | https://conductscience.org/library/papers/31333640 | PubMed |
| 31107218 | Pertactin-Negative and Filamentous Hemagglutinin-Negative Bordetella pertussis, Australia, 2013-2017. | Emerg Infect Dis | 2019 | https://conductscience.org/library/papers/31107218 | PubMed |
| 30782265 | Pertactin-deficient Bordetella pertussis isolates: evidence of increased circulation in Europe, 1998 to 2015. | Euro Surveill | 2019 | https://conductscience.org/library/papers/30782265 | PubMed |
| 30559199 | Why the evolution of vaccine resistance is less of a concern than the evolution of drug resistance. | Proc Natl Acad Sci U S A | 2018 | https://conductscience.org/library/papers/30559199 | PubMed |
| 29771235 | Bordetella pertussis population dynamics and phylogeny in Japan after adoption of acellular pertussis vaccines. | Microb Genom | 2018 | https://conductscience.org/library/papers/29771235 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28322702
GET https://conductscience.org/api/papers/v1/28322702/authors